Ning Wu

483 total citations
33 papers, 391 citations indexed

About

Ning Wu is a scholar working on Cardiology and Cardiovascular Medicine, Economics and Econometrics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ning Wu has authored 33 papers receiving a total of 391 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 7 papers in Economics and Econometrics and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ning Wu's work include Atrial Fibrillation Management and Outcomes (7 papers), Health Systems, Economic Evaluations, Quality of Life (7 papers) and Multiple Sclerosis Research Studies (5 papers). Ning Wu is often cited by papers focused on Atrial Fibrillation Management and Outcomes (7 papers), Health Systems, Economic Evaluations, Quality of Life (7 papers) and Multiple Sclerosis Research Studies (5 papers). Ning Wu collaborates with scholars based in United States, China and United Kingdom. Ning Wu's co-authors include Christian Hirsch, Luke Boulanger, Andrew L. Wit, Shih‐Yin Chen, Yanni Yu, Shih‐Yin Chen, David Coultas, Catherine J. Mercaldi, Stephen Sander and You Wu and has published in prestigious journals such as Journal of the American College of Cardiology, Neurology and CHEST Journal.

In The Last Decade

Ning Wu

31 papers receiving 382 citations

Peers

Ning Wu
Peter Vaško Czechia
J Vos Netherlands
E Grasso Italy
M. Kentsch Germany
Axel Müller Germany
Jan Tijssen Netherlands
Ning Wu
Citations per year, relative to Ning Wu Ning Wu (= 1×) peers Silvia Calabria

Countries citing papers authored by Ning Wu

Since Specialization
Citations

This map shows the geographic impact of Ning Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ning Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ning Wu more than expected).

Fields of papers citing papers by Ning Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ning Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ning Wu. The network helps show where Ning Wu may publish in the future.

Co-authorship network of co-authors of Ning Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Ning Wu. A scholar is included among the top collaborators of Ning Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ning Wu. Ning Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Ning, Chen‐Hua Yan, Jun Kong, et al.. (2025). Prophylactic Versus Preemptive Donor Lymphocyte Infusion in Refractory/Relapsed AML Post-Allogeneic Transplant: A Retrospective Comparative Study. Transplantation and Cellular Therapy. 32(3). 302.e1–302.e10.
3.
Wallick, Christopher J., et al.. (2023). Impact of antiviral therapy on short‐ and long‐term outcomes of patients with chronic obstructive pulmonary disease after influenza infection. Influenza and Other Respiratory Viruses. 17(12). e13231–e13231. 1 indexed citations
4.
Liu, Yuewen, Ning Wu, Hui Zhang, et al.. (2021). Obesity, Even in the Metabolically Healthy, Increases the Risk of Poor Physical Performance: A Cross-Sectional Study of Older People in a Chinese Community. Clinical Interventions in Aging. Volume 16. 697–706. 5 indexed citations
5.
Tang, Wei, Fei Wang, Jianwei Wang, et al.. (2021). Developing a Screening Procedure During the COVID-19 Pandemic: Process and Challenges Faced by a Low-Incidence Area. Frontiers in Medicine. 8. 654754–654754. 1 indexed citations
6.
Exuzides, Alex, et al.. (2021). Identification and temporal trends of patients with neuromyelitis optica spectrum disorder in a US insurance claims database. Journal of Medical Economics. 24(1). 581–588. 3 indexed citations
7.
Cohan, Stanley, Kyle Smoot, Robert B. Garland, et al.. (2018). Outcomes of Stable Multiple Sclerosis Patients Staying on Initial Interferon Beta Therapy Versus Switching to Another Interferon Beta Therapy: A US Claims Database Study. Advances in Therapy. 35(11). 1894–1904. 5 indexed citations
9.
Nicholas, Jacqueline, Daniel Ontaneda, Ning Wu, et al.. (2017). Development of an Algorithm to Identify Multiple Sclerosis (MS) Disease Severity Based on Healthcare Costs in a US Administrative Claims Database (P2.052). Neurology. 88(16_supplement). 10 indexed citations
10.
Yu, Yanni, et al.. (2016). Patterns and Economic Burden of Hospitalizations and Exacerbations Among Patients Diagnosed with Idiopathic Pulmonary Fibrosis. Journal of Managed Care & Specialty Pharmacy. 22(4). 414–423. 33 indexed citations
11.
Wu, Ning, Xuezhong Zhang, Wen Wang, & Hongye Zhang. (2015). Validation of the Andon KD595 for clinical use and self-measurement according to the European Society of Hypertension International Protocol. Blood Pressure Monitoring. 21(2). 124–127. 1 indexed citations
12.
Amin, Alpesh, Michael Stokes, Dinara Makenbaeva, et al.. (2014). MEDICAL COSTS AVOIDED FOR PREVENTION OF STROKE WITH USE OF NOACS: ESTIMATES FOR THE REAL-WORLD. Journal of the American College of Cardiology. 63(12). A330–A330. 1 indexed citations
13.
Amin, Alpesh, Michael Stokes, Dinara Makenbaeva, et al.. (2014). Estimated medical cost reductions associated with use of novel oral anticoagulants vs warfarin in a real-world non-valvular atrial fibrillation patient population. Journal of Medical Economics. 17(11). 771–781. 11 indexed citations
15.
Andrews, Jeffrey G., Ning Wu, Shih‐Yin Chen, et al.. (2013). Real-world treatment patterns and opioid use in chronic low back pain patients initiating duloxetine versus standard of care. Journal of Pain Research. 6. 825–825. 12 indexed citations
16.
Chen, Shih‐Yin, Ning Wu, Michael P. Gulseth, et al.. (2013). One-Year Adherence to Warfarin Treatment for Venous Thromboembolism in High-Risk Patients and Its Association with Long-term Risk of Recurrent Events. Journal of Managed Care Pharmacy. 19(4). 291–301. 50 indexed citations
17.
Plauschinat, Craig, et al.. (2011). Economic impact of using inhaled corticosteroids without prior exacerbation among elderly patients with chronic obstructive pulmonary disorder. Journal of Medical Economics. 14(4). 458–462. 6 indexed citations
18.
Swearingen, Brooke, Ning Wu, Shih‐Yin Chen, Sonia Pulgar, & Beverly M. K. Biller. (2011). Health Care Resource Use and Costs Among Patients with Cushing Disease. Endocrine Practice. 17(5). 681–690. 33 indexed citations
19.
Wu, Ning & Christian Hirsch. (2010). Temporomandibular Disorders in German and Chinese Adolescents. Journal of Orofacial Orthopedics / Fortschritte der Kieferorthopädie. 71(3). 187–198. 44 indexed citations
20.
Wan, Qing, et al.. (1992). Clinical manifestations and prevalence of different types of supraventricular tachycardia among Chinese.. PubMed. 105(4). 284–8. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026